| |
|
|
 |
|
A Catalyst for Antiphospholipid
Syndrome ResearchMarch 2011 - The treatment of the serious, potentially fatal autoimmune clotting disorder antiphospholipid syndrome (APS) has, in general, been empiric and based on various approaches to inhibit the clotting system.
Read More
Little-Studied Blood Syndrome Gains
Researchers' AttentionMarch 15, 2011 - Motivated by the lack of treatment options for patients with antiphospholipid syndrome (APS), rheumatology researchers convened an international committee to address the problem directly. Read More
International Summit Held
to Stimulate Collaborative Clinical Research on Antiphospholipid SyndromeNovember 2, 2010 - Antiphospholipid Syndrome (APS) is a condition that may be responsible for up to one-third of strokes in people under age 50, up to one-fifth of all cases of blood clots in large veins, and one-quarter of recurrent miscarriages. Read More |
International Network to Launch Clinical Trials Worldwide
Antiphospholipid Syndrome is a life-threatening autoimmune disorder in which your immune system mistakenly produces antibodies against certain normal proteins in your blood – causing blood clots within your arteries or veins as well as pregnancy complications, such as miscarriages and stillbirths.
It is a leading cause of stroke in young people, responsible for 1 out of 3 strokes in people under 50, 1 out of 5 recurrent miscarriages, and up to 20% of all deep-vein blood clots (DVT).
APS Action is a network of internationally renown physicians and scientists that works to find a cure for Antiphospholopid Syndrome. Members of the steering committee for APS Action include:
|
Laura Andreoli
University of Brescia,
Brescia, Italy
University of Utah School of
Medicine, Salt Lake City, UT, USA
Robin Brey
University of Texas Health Science Center, San Antonio, TX, USA
Hospital Clinic, Barcelona,
Catalonia, Spain
Hannah Cohen
University College London
Hospitals, London, UK
Maria Cuadrado
St. Thomas Hospital,
London, England
Philip deGroot
University Medical Centre,
Utrecht, Netherlands
University Medical Centre,
Utrecht, Netherlands
Hospital for Special Surgery,
New York, NY, USA
Centre Hospitalier Universitaire
de Quebec, Quebec, Canada
|
Bill Giannakopoulos
St. George Hospital, University
of
New South Wales,
Sydney, Australia
Nigel Harris
University of West Indies,
Jamaica
Munther Khamashta
St. Thomas Hospital,
London, England
Steve Krilis St. George Hospital, University
of New South Wales,
Sydney, Australia
Steven R. Levine SUNY Health Science Center, Downstate Stroke Center,
Brooklyn, NY, USA
Roger Levy Universidade do Estado do
Rio de Janeiro, Brazil
Hospital for Special Surgery,
New York, NY, USA
Sam Machin
University College London
Hospitals, London, UK
Pierluigi Meroni
University of Milan,
Milan, Italy
|
Tom Ortel
Duke University Medical Center,
Durham, NC, USA
Vittorio Pengo
University Hospital,
Padova, Italy
University of Texas Medical Branch, Galveston, Texas, USA
Hospital Clínic, Barcelona,
Catalonia, Spain
Jacob Rand
Montefiore Medical Center,
Bronx, NY, USA
Robert Roubey
University of North Carolina,
Chapel Hill, NC, USA
Hospital for Special Surgery,
New York, NY, USA
Angela Tincani
University of Brescia,
Brescia, Italy
Denis Wahl
Nancy University,
Nancy, France
|
|
| |
|
